Pages that link to "Q27266125"
Jump to navigation
Jump to search
The following pages link to The JAK2V617F activating mutation occurs in chronic myelomonocytic leukemia and acute myeloid leukemia, but not in acute lymphoblastic leukemia or chronic lymphocytic leukemia (Q27266125):
Displayed 50 items.
- The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes (Q22299206) (← links)
- JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis (Q24609999) (← links)
- Reticulin accumulation in essential thrombocythemia: prognostic significance and relationship to therapy (Q24631288) (← links)
- Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies (Q24648438) (← links)
- Molecular allelokaryotyping of pediatric acute lymphoblastic leukemias by high-resolution single nucleotide polymorphism oligonucleotide genomic microarray (Q24650855) (← links)
- The diagnosis of BCR/ABL-negative chronic myeloproliferative diseases (CMPD): a comprehensive approach based on morphology, cytogenetics, and molecular markers (Q24675681) (← links)
- Transformation of hematopoietic cells and activation of JAK2-V617F by IL-27R, a component of a heterodimeric type I cytokine receptor (Q24676526) (← links)
- Erlotinib effectively inhibits JAK2V617F activity and polycythemia vera cell growth (Q24685474) (← links)
- Chronic neutrophilic leukemia: a clinical perspective (Q26781167) (← links)
- Risk of Infectious Complications in Hemato-Oncological Patients Treated with Kinase Inhibitors (Q26851417) (← links)
- Janus kinase deregulation in leukemia and lymphoma (Q26991810) (← links)
- Chronic neutrophilic leukemia 2014: Update on diagnosis, molecular genetics, and management (Q27009366) (← links)
- JAK2 and genomic instability in the myeloproliferative neoplasms: a case of the chicken or the egg? (Q27012572) (← links)
- (Q27266139) (redirect page) (← links)
- CIViC database (Q27612411) (← links)
- Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1 (Q27687464) (← links)
- Recent advances in diagnosis, molecular pathology and therapy of chronic myelomonocytic leukaemia (Q28307278) (← links)
- JAK2 V617F (Q28429317) (← links)
- Differential biological activity of disease-associated JAK2 mutants (Q28508045) (← links)
- The role of Janus Kinase 2 V617F mutation in extramedullary hematopoiesis of the spleen in neoplastic myeloid disorders (Q33291373) (← links)
- RNAi screening of the tyrosine kinome identifies therapeutic targets in acute myeloid leukemia (Q33306326) (← links)
- SNP array karyotyping allows for the detection of uniparental disomy and cryptic chromosomal abnormalities in MDS/MPD-U and MPD. (Q33306707) (← links)
- JAK and MPL mutations in myeloid malignancies (Q33378737) (← links)
- MS-1020 is a novel small molecule that selectively inhibits JAK3 activity (Q33507716) (← links)
- Design and evaluation of a real-time PCR assay for quantification of JAK2 V617F and wild-type JAK2 transcript levels in the clinical laboratory (Q33555643) (← links)
- Oncogenic JAK1 and JAK2-activating mutations resistant to ATP-competitive inhibitors (Q33843072) (← links)
- JAK2 V617F detected in two B-cell chronic lymphocytic leukemia patients without coexisting Philadelphia chromosome-negative myeloproliferative neoplasms: A report of two cases (Q33843882) (← links)
- Molecular therapy for acute myeloid leukaemia (Q33925672) (← links)
- CYT387, a novel JAK2 inhibitor, induces hematologic responses and normalizes inflammatory cytokines in murine myeloproliferative neoplasms (Q33944270) (← links)
- c-Abl activates janus kinase 2 in normal hematopoietic cells (Q33985308) (← links)
- A Non-ATP-Competitive Dual Inhibitor of JAK2 and BCR-ABL Kinases: Elucidation of a Novel Therapeutic Spectrum Based on Substrate Competitive Inhibition (Q34065882) (← links)
- Germline CBL mutations cause developmental abnormalities and predispose to juvenile myelomonocytic leukemia (Q34130332) (← links)
- TET2 mutations are associated with specific 5-methylcytosine and 5-hydroxymethylcytosine profiles in patients with chronic myelomonocytic leukemia (Q34157339) (← links)
- Expression of a homodimeric type I cytokine receptor is required for JAK2V617F-mediated transformation (Q34245259) (← links)
- Kinase pathway dependence in primary human leukemias determined by rapid inhibitor screening (Q34307423) (← links)
- Simultaneous and sequential concurrent myeloproliferative and lymphoproliferative neoplasms (Q34519513) (← links)
- The stilbenoid tyrosine kinase inhibitor, G6, suppresses Jak2-V617F-mediated human pathological cell growth in vitro and in vivo (Q34575802) (← links)
- The JAK2 V617F somatic mutation, mortality and cancer risk in the general population (Q34612649) (← links)
- TG101209, a small molecule JAK2-selective kinase inhibitor potently inhibits myeloproliferative disorder-associated JAK2V617F and MPLW515L/K mutations (Q34633315) (← links)
- Molecular genetics of chronic neutrophilic leukemia, chronic myelomonocytic leukemia and atypical chronic myeloid leukemia (Q34700714) (← links)
- Genomic and functional analysis of leukemic transformation of myeloproliferative neoplasms. (Q34752547) (← links)
- Small molecule inhibitors in acute myeloid leukemia: from the bench to the clinic (Q34817365) (← links)
- Enu mutagenesis identifies a novel platelet phenotype in a loss-of-function Jak2 allele (Q35005652) (← links)
- The prognostic impact of germline 46/1 haplotype of Janus kinase 2 in cytogenetically normal acute myeloid leukemia. (Q35528622) (← links)
- JAK2(V617F): Prevalence in a large Chinese hospital population (Q35615806) (← links)
- Detection of the activating JAK2 V617F mutation in paraffin-embedded trephine bone marrow biopsies of patients with chronic myeloproliferative diseases (Q35790195) (← links)
- JAK2 V617F in myeloid disorders: molecular diagnostic techniques and their clinical utility: a paper from the 2005 William Beaumont Hospital Symposium on Molecular Pathology (Q35790260) (← links)
- Limited efficacy of BMS-911543 in a murine model of Janus kinase 2 V617F myeloproliferative neoplasm (Q35805105) (← links)
- JAK2 V617F: a single mutation in the myeloproliferative group of disorders (Q35841611) (← links)
- Torque teno virus 10 isolated by genome amplification techniques from a patient with concomitant chronic lymphocytic leukemia and polycythemia vera. (Q35876861) (← links)